ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1719

Prevalence and Trajectory of Erosions, Synovitis, and Bone Marrow Edema in Feet of Patients with Early Rheumatoid Arthritis

Zechen Ma1, Hanyan Zou2, Mary-Clair Yelovich2, Saara Totterman3, Karen Beattie2 and Maggie Larche2, 1McMaster University, Mississauga, ON, Canada, 2McMaster University, Hamilton, ON, Canada, 3QMetrics Technologies, Rochester, NY

Meeting: ACR Convergence 2020

Keywords: Erosions, foot, Magnetic resonance imaging (MRI), rheumatoid arthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 9, 2020

Title: RA – Diagnosis, Manifestations, & Outcomes Poster IV: Lifespan of a Disease

Session Type: Poster Session D

Session Time: 9:00AM-11:00AM

Background/Purpose: Imaging studies have shown that erosions emerge early in RA and is associated with worsening pain and function. Despite erosions being just as prevalent in feet as in hands in patients with RA, their development in relation to synovitis and bone marrow edema (BME) have mainly been studied in the hands. This study examines the prevalence and longitudinal trajectory of erosions, BME, and synovitis in metatarsophalangeal joints (MTPJs) in patients with early RA over 2 years of treatment. We also describe correlations between changes in erosions, synovitis, and BME at the joint level.

Methods: Treatment naïve patients with early RA (symptom duration < 2 years) were recruited from an academic rheumatology clinic. MRI of the most symptomatic forefoot was acquired at baseline, year 1 and ≥2 years using a 1.0T peripheral scanner (GE Medical). Metatarsophalangeal joints 2-5 were semi-quantitatively graded by a MSK radiologist for erosions (0-10), synovitis (0-3) and BME (0-3) according to OMERACT guidelines. Synovitis was graded per joint, while erosions and BME were graded for the metatarsal head and phalangeal base individually so the maximum scores per MTPJ were 20 for erosions and 6 for BME. The MSK radiologist was blinded to clinical assessments and previous imaging. Patients were treated per standard of care. Descriptive statistics characterized the study population. Paired t-tests were performed for changes in erosions, synovitis, and BME over time. Correlations between changes in erosions, synovitis, and BME were conducted per joint using Pearson’s correlation coefficient.

Results: 32 patients with early RA were included. 87.5% of patients were female and the average age was 51.7 (SD=10.4). At baseline, 29 patients (90.6%) had at least one grade ≥1 erosion, 21 (65.6%) had at least one MTPJ with grade ≥1 synovitis, and 19 (61.3%) had at least one joint with grade ≥1 BME. The proportion of MTPJs with erosions, synovitis, and BME are shown in Table 1. Overall changes in erosions, synovitis, and BME are shown in Figure 1. Erosions overall did not significantly change over time. Significant reductions in overall synovitis scores, MTPJ2, and MTPJ3 synovitis scores were seen between year 1 and ≥2 years.  Overall BME scores improved in year 1 and were sustained at ≥2 years. BME improved in MTPJ2, MTPJ3, and MTPJ4. Positive correlations were seen between changes in synovitis and BME in MTPJ2 and MTPJ5.

Conclusion: In patients with early RA, standard of care saw overall reductions in synovitis by year 2, BME by year 1, and no progression in overall erosion scores on MRI. MTPJ2 and MTPJ3 appeared to be the most active joints.  Overall improvements in synovitis is attributed to MTPJ2 and MTPJ3, while other MTPJs did not progress. Over all reductions in BME is attributed to MTPJ2, MTPJ3, and MTPJ4, while other MTPJs did not progress. 

Table 1. Proportion of joints with erosions, synovitis, and BME over time

Figure 1. Longitudinal changes in overall erosions, synovitis, and BME


Disclosure: Z. Ma, None; H. Zou, None; M. Yelovich, None; S. Totterman, None; K. Beattie, None; M. Larche, AbbVie, 5, Amgen, 5, Boehringer-Ingelheim, 5, BMS, 5, Celgene, 5, Janssen, 5, Mallinckrodt, 5, Novartis, 5, Pfizer, 5, Roche, 5, Sandoz, 5, UCB, 5.

To cite this abstract in AMA style:

Ma Z, Zou H, Yelovich M, Totterman S, Beattie K, Larche M. Prevalence and Trajectory of Erosions, Synovitis, and Bone Marrow Edema in Feet of Patients with Early Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/prevalence-and-trajectory-of-erosions-synovitis-and-bone-marrow-edema-in-feet-of-patients-with-early-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/prevalence-and-trajectory-of-erosions-synovitis-and-bone-marrow-edema-in-feet-of-patients-with-early-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology